文献速递主动脉外科

非直径主动脉指数对手术资格的影响:TITAN: SvS随机对照试验结果

Impact of nondiameter aortic indices on surgical eligibility: Results from the Treatment in Thoracic Aortic Aneurysm: Surgery Versus Surveillance (TITAN: SvS) randomized controlled trial.
PubMed 文献 · J Thorac Cardiovasc Surg · 2024-04-29

本研究基于TITAN: SvS随机对照试验的前瞻性多中心队列,评估2022年ACC/AHA指南采用的三种非直径主动脉指数对5.0–5.4 cm升主动脉瘤患者手术资格的影响。329例患者中,20%为女性,平均年龄65.0±11.6岁,平均最大主动脉直径为50.8±3.9 mm;三分之一患者(n=109)符合任一非直径标准,女性较男性更常满足这些标准。

要点

  • 在5.0–5.4 cm升主动脉瘤患者中,三分之一(n=109)符合至少一项非直径手术标准。
  • 女性较男性更常满足主动脉大小指数、主动脉高度指数和横截面积/身高比标准。
  • 非直径标准使部分未达5.5 cm直径阈值的患者符合手术干预条件。

核心结论

  • 在TITAN: SvS试验中,三分之一患者基于新参数符合手术干预标准,而经典标准为直径5.5 cm或以上。
  • 女性较男性更可能满足主动脉大小指数、主动脉高度指数或横截面积/身高比的手术阈值。

研究设计与样本

  • 研究纳入2018至2023年多中心试验TITAN: SvS随机分组或注册组的患者。
  • 临床数据前瞻性录入在线数据库,影像数据来自核心计算实验室。
  • 共纳入329例患者,20%为女性,平均年龄65.0±11.6岁,平均最大主动脉直径50.8±3.9 mm。

主要发现

  • 符合任一非直径标准(主动脉大小指数≥3.08 cm/m²、主动脉高度指数≥3.21 cm/m或横截面积/身高≥10 cm²/m)的患者共109例(占三分之一),其平均最大主动脉直径为52.5±0.52 mm。
  • 女性 vs 男性满足主动脉大小指数标准比例为20% vs 2%(P < .001)。
  • 女性 vs 男性满足主动脉高度指数标准比例为39% vs 5%(P < .001)。
  • 女性 vs 男性满足横截面积/身高标准比例为39% vs 21%(P = .002)。

关键数值与推荐

  • 传统干预标准为无症状升主动脉瘤最大直径5.5 cm或以上。
  • 2022年ACC/AHA主动脉指南采用横截面积/身高比、主动脉大小指数和主动脉高度指数作为手术干预的替代参数。
  • 本研究中非直径标准阈值为:主动脉大小指数≥3.08 cm/m²、主动脉高度指数≥3.21 cm/m或横截面积/身高≥10 cm²/m。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Traditional criterion for intervention on an asymptomatic ascending aortic aneurysm has been a maximal aortic diameter of 5.5 cm or more. The 2022 American College of Cardiology/American Heart Association aortic guidelines adopted cross-sectional aortic area/height ratio, aortic size index, and aortic height index as alternate parameters for surgical intervention. The objective of this study was to evaluate the impact of using these newer indices on patient eligibility for surgical intervention in a prospective, multicenter cohort with moderate-sized ascending aortic aneurysms between 5.0 and 5.4 cm. METHODS: Patients enrolled from 2018 to 2023 in the randomization or registry arms of the multicenter trial, Treatment In Thoracic Aortic aNeurysm: Surgery versus Surveillance, were included in the study. Clinical data were captured prospectively in an online database. Imaging data were derived from a core computed laboratory. RESULTS: Among the 329 included patients, 20% were female. Mean age was 65.0 ± 11.6 years, and mean maximal aortic diameter was 50.8 ± 3.9 mm. In the one-third of all patients (n = 109) who met any 1 of the 3 criteria (ie, aortic size index ≥3.08 cm/m2, aortic height index ≥3.21 cm/m, or cross-sectional aortic area/height ≥ 10 cm2/m), their mean maximal aortic diameter was 52.5 ± 0.52 mm. Alternate criteria were most commonly met in women compared with men: 20% versus 2% for aortic size index (P < .001), 39% versus 5% for aortic height index (P < .001), and 39% versus 21% for cross-sectional aortic area/height (P = .002), respectively. CONCLUSIONS: One-third of patients in Treatment In Thoracic Aortic aNeurysm: Surgery versus Surveillance would meet criteria for surgical intervention based on novel parameters versus the classic definition of diameter 5.5 cm or more. Surgical thresholds for aortic size index, aortic height index, or cross-sectional aortic area/height ratio are more likely to be met in female patients compared with male patients.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Dagher O, Appoo JJ, Herget E, et al. Impact of nondiameter aortic indices on surgical eligibility: Results from the Treatment in Thoracic Aortic Aneurysm: Surgery Versus Surveillance (TITAN: SvS) randomized controlled trial. J Thorac Cardiovasc Surg. 2024. PMID: 38692478. doi:10.1016/j.jtcvs.2024.04.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。